Clinical Studies

Clinical Studies

Clinical Studies on Penile Erection and Treatment of Erectile Dysfunction

Clinical Study on efficacy of Viberect X3 for Facilitating Ejaculation

Clinical Study on Retarded Orgasm

Clinical Study on Basic Science and Genital Afferent Neurophysiology

Certifications of The Viberect®

FDA (USA), CE (European Union), ISO 13485:2003, CMDCAS, Health Canada, TGA (Australia), EN 60601-3, India

FDA Indications:
Class II medical device for home and clinic use to provoke penile erection in men with erectile dysfunction, and to provoke ejaculation in men with spinal cord injury.

CE Indications:
Penile vibratory stimulation device for the treatment of erectile and ejaculatory disorders.